PO Box 270670
CO 80527 Fort Collins, us
InVitria Taps Industry Expert to Launch Cell Culture Supplements Product Line
Shawn joined InVitria to focus on expanding the reach in currently served markets, as well as to develop a presence in promising new market segments. Shawn comes to InVitria with over 20 years of experience in cell culture and industrial bioproduction business. He held previous posts at Life Technologies' Invitrogen/GIBCO cell culture media and supplements business unit, where he was Business Segment Director for Industrial BioProduction. In addition, Shawn was Global Market Director for Kerry Biosciences (Sheffield) and Global Sales Director at Thermo Fisher - HyClone.
"Shawn's proven track record and cell culture expertise are a true asset to any team he's been a part of and we are excited that he has joined the InVitria team," said Scott Deeter, CEO/President of InVitria. "2011 will be an exciting year and we look forward to continued growth with Shawn's leadership."
"Leading sales and marketing of an exciting, progressive organization with the innovative product line developed by InVitria is truly energizing. I look forward to advancing the commercialization of these products. I believe the InVitria technology is genuinely a breakthrough for our industry that will achieve what many of us have dreamed about: a high performance, completely animal component free and well defined cell culture system."
Shawn will share his perspective regarding the latest industry trends in an upcoming webinar on January 27th, 2011, titled Enabling Success in the Biologics World: Latest Trends in Cell Culture Science. Shawn will discuss recent developments in new biologic drug approvals, biosimilars, cell-based vaccines, stem cells and regenerative medicine, and how InVitria products contribute to customers working in these areas. Click here to register today.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to email@example.com.